Journal of the American Geriatrics Society

 
 

  • Deprescribing in the Pharmacologic Management of Delirium Can an EHR/pharmacist-based deprescribing intervention be effective in reducing anticholinergic and benzodiazepine use in hospitalized elderly patients? What impact might it have on delirium outcomes?
  • Action Steps for Older Adults With Multiple Chronic Conditions The AGS presents a framework of actions and accompanying action steps for decision making for clinicians who provide both primary and specialty care to older people with multiple chronic conditions.
  • Using Wisely: The Proper Use of the AGS Beers Criteria The Beers Criteria provides recommendations for drugs that should often be avoided for older adults. How should it be applied in a way that maximizes benefits while minimizing unintended harms?
  • CPAP Adherence and Cognitive Decline in Adults With MCI, OSA This study demonstrated a beneficial effect of CPAP adherence on multiple domains of cognitive function in persons with mild cognitive impairment and obstructive sleep apnea.
  • Polypharmacy and Outcome in Patients on Vitamin K Antagonists What impact does polypharmacy have on the quality and outcome of anticoagulation therapy with Vitamin K antagonists?
  • How Chronic Is Polypharmacy in Old Age? How prevalent is polypharmacy among older adults, and what factors are associated with chronic rather than transient polypharmacy?
  • Psychoactive Medications in Older Adults on Hemodialysis Are psychoactive medications, such as sedative-hypnotics, and antidepressants with anticholinergic properties, associated with major adverse outcomes among older hemodialysis patients?
  • Antimicrobial Stewardship Programs in Long-term Care Settings How are antimicrobial stewardship interventions being implemented in long-term care facilities, and what are the unique challenges these settings present?
  • Pharmacotherapy in Older Adults With Cardiovascular Disease Review the recommendations of a recent multidisciplinary workshop focused on determining top priority areas for research to optimize pharmacotherapy in older adults with cardiovascular disease.
  • Cataract and Risks of Osteoporosis and Fracture Are individuals with cataract at higher risks of osteoporosis and fracture than those without?
  • Inclusion of Older Adults in NIH-Funded Clinical Trials Are older adults being underrepresented in clinical studies due to upper age limits for recruitment and exclusion criteria that include illnesses and medications common in the older population?
  • Tools for Deprescribing in Frail Older Persons The authors evaluated 15 tools designed to assist clinicians in identifying and reducing or stopping potentially inappropriate medications in frail older persons or those near the end of life.
  • Ten Things Every Geriatrician Should Know About House Calls This brief review outlines key concepts which provide geriatricians and other care team members with the practical knowledge needed to include home-based primary care in routine practice.
  • PIMs in Older Adults: Deprescribing With a Clinical Pharmacist This study evaluated the effect an interdisciplinary team which includes a clinical pharmacy specialist would have on deprescribing of potentially inappropriate medications in older adults.
  • Exnovation of Low Value Care: A Decade of PSA Screening Why do physicians continue to recommend PSA screening in contradiction to current guidelines? This study aimed to determine which factors might influence or serve as barriers to practice change.
  • Primary Headache Disorders in Older Adults This review provides a guide to the challenges inherent in diagnosing and treating headaches in older adults, including potential polypharmacy, comorbidities, and changes associated with aging.
  • Preventing Postop Delirium After Noncardiac Thoracic Surgery Is low-dose postoperative haloperidol effective in reducing delirium in individuals undergoing non-cardiac thoracic surgery?
  • Serum Cholesterol and Incident Alzheimer's Disease Is there a relationship between cholesterol levels and risk of Alzheimer disease, and how might risk vary among specific age groups?
  • Functional Performance and Alzheimer's Disease Biomarkers This findings of this study support an association between functional performance and Alzheimer disease neuroimaging biomarkers very early in the dementia pathophysiology.
  • AF: Rate and Rhythm Control and Cognitive Performance Does controlling rate in older persons with atrial fibrillation affect cognition differently than controlling rhythm?